| Tretinoin | Approved Investigational Nutraceutical | ANGPTL4 | 51129 |
upregulated | Tretinoin results in increased expression of ANGPTL4 mRNA | 19p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANK2 | 287 |
downregulated | Tretinoin results in decreased expression of ANK2 mRNA | 4q25-q26 | |
| Tretinoin | Approved Investigational Nutraceutical | ANK3 | 288 |
upregulated | Tretinoin results in increased expression of ANK3 mRNA | 10q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKH | 56172 |
upregulated | Tretinoin results in increased expression of ANKH mRNA | 5p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKIB1 | 54467 |
upregulated | Tretinoin results in increased expression of ANKIB1 mRNA | 7q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRA2 | 57763 |
upregulated | Tretinoin results in increased expression of ANKRA2 mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD17 | 26057 |
downregulated | Tretinoin results in decreased expression of ANKRD17 mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD2 | 26287 |
upregulated | Tretinoin results in increased expression of ANKRD2 mRNA | 10q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD22 | 118932 |
upregulated | Tretinoin results in increased expression of ANKRD22 mRNA | 10q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD28 | 23243 |
downregulated | Tretinoin results in decreased expression of ANKRD28 mRNA | 3p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD33B | 651746 |
upregulated | Tretinoin results in increased expression of ANKRD33B mRNA | 5p15.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD42 | 338699 |
upregulated | Tretinoin results in increased expression of ANKRD42 mRNA | 11q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD44 | 91526 |
upregulated | Tretinoin results in increased expression of ANKRD44 mRNA | 2q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKRD46 | 157567 |
upregulated | Tretinoin results in increased expression of ANKRD46 mRNA | 8q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKS1B | 56899 |
downregulated | Tretinoin results in decreased expression of ANKS1B mRNA | 12q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKS6 | 203286 |
downregulated | Tretinoin results in decreased expression of ANKS6 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ANKS6 | 203286 |
upregulated | Tretinoin results in increased expression of ANKS6 mRNA | 9q22.33 | |
| Tretinoin | Approved Investigational Nutraceutical | ANO1 | 55107 |
upregulated | Tretinoin results in increased expression of ANO1 mRNA | 11q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ANO2 | 57101 |
downregulated | Tretinoin results in decreased expression of ANO2 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ANO3 | 63982 |
downregulated | Tretinoin results in decreased expression of ANO3 mRNA | 11p14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ANO6 | 196527 |
upregulated | Tretinoin results in increased expression of ANO6 mRNA | 12q12 | |
| Tretinoin | Approved Investigational Nutraceutical | ANOS1 | 3730 |
downregulated | Tretinoin results in decreased expression of ANOS1 mRNA | Xp22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ANOS1 | 3730 |
upregulated | Tretinoin results in increased expression of ANOS1 mRNA | Xp22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | ANP32A | 8125 |
downregulated | Tretinoin results in decreased expression of ANP32A mRNA | 15q23 | |
| Tretinoin | Approved Investigational Nutraceutical | ANTXR1 | 84168 |
upregulated | Tretinoin results in increased expression of ANTXR1 mRNA | 2p13.3 | |